BIOMERIEUX (BIM.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:BIM - FR0013280286 - Common Stock
108 EUR
-1.4 (-1.28%)
We assign a fundamental rating of 6 out of 10 to BIM. BIM was compared to 68 industry peers in the Health Care Equipment & Supplies industry. While BIM has a great health rating, its profitability is only average at the moment. BIM has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
BIM had positive earnings in the past year.
BIM had a positive operating cash flow in the past year.
BIM had positive earnings in each of the past 5 years.
Each year in the past 5 years BIM had a positive operating cash flow.
1.2 Ratios
The Return On Assets of BIM (7.04%) is better than 79.41% of its industry peers.
Looking at the Return On Equity, with a value of 9.61%, BIM is in the better half of the industry, outperforming 61.76% of the companies in the same industry.
BIM has a better Return On Invested Capital (8.56%) than 70.59% of its industry peers.
BIM had an Average Return On Invested Capital over the past 3 years of 10.05%. This is in line with the industry average of 9.73%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.04% | ||
| ROE | 9.61% | ||
| ROIC | 8.56% |
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
1.3 Margins
BIM has a better Profit Margin (9.17%) than 63.24% of its industry peers.
BIM's Profit Margin has been stable in the last couple of years.
BIM has a Operating Margin (12.38%) which is in line with its industry peers.
BIM's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 56.27%, BIM perfoms like the industry average, outperforming 52.94% of the companies in the same industry.
In the last couple of years the Gross Margin of BIM has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.38% | ||
| PM (TTM) | 9.17% | ||
| GM | 56.27% |
OM growth 3Y-12.86%
OM growth 5Y2.09%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
2. Health
2.1 Basic Checks
BIM has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, BIM has about the same amount of shares outstanding.
Compared to 5 years ago, BIM has less shares outstanding
Compared to 1 year ago, BIM has an improved debt to assets ratio.
2.2 Solvency
BIM has an Altman-Z score of 6.82. This indicates that BIM is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of BIM (6.82) is better than 92.65% of its industry peers.
The Debt to FCF ratio of BIM is 1.15, which is an excellent value as it means it would take BIM, only 1.15 years of fcf income to pay off all of its debts.
BIM's Debt to FCF ratio of 1.15 is amongst the best of the industry. BIM outperforms 85.29% of its industry peers.
BIM has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
BIM has a better Debt to Equity ratio (0.09) than 79.41% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 1.15 | ||
| Altman-Z | 6.82 |
ROIC/WACC1.08
WACC7.91%
2.3 Liquidity
A Current Ratio of 2.27 indicates that BIM has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.27, BIM is doing good in the industry, outperforming 66.18% of the companies in the same industry.
BIM has a Quick Ratio of 1.30. This is a normal value and indicates that BIM is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of BIM (1.30) is better than 61.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.27 | ||
| Quick Ratio | 1.3 |
3. Growth
3.1 Past
BIM shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.45%.
The Earnings Per Share has been growing by 10.91% on average over the past years. This is quite good.
The Revenue has grown by 8.28% in the past year. This is quite good.
BIM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.27% yearly.
EPS 1Y (TTM)-8.45%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%-25.82%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%7.46%
3.2 Future
The Earnings Per Share is expected to grow by 11.79% on average over the next years. This is quite good.
Based on estimates for the next years, BIM will show a small growth in Revenue. The Revenue will grow by 5.72% on average per year.
EPS Next Y16.45%
EPS Next 2Y14.56%
EPS Next 3Y13.42%
EPS Next 5Y11.79%
Revenue Next Year5.19%
Revenue Next 2Y5.72%
Revenue Next 3Y6.1%
Revenue Next 5Y5.72%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 27.98, BIM can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as BIM.
Compared to an average S&P500 Price/Earnings ratio of 27.30, BIM is valued at the same level.
With a Price/Forward Earnings ratio of 21.32, BIM is valued on the expensive side.
BIM's Price/Forward Earnings is on the same level as the industry average.
BIM is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 24.04, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.98 | ||
| Fwd PE | 21.32 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BIM indicates a somewhat cheap valuation: BIM is cheaper than 72.06% of the companies listed in the same industry.
63.24% of the companies in the same industry are more expensive than BIM, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 29.13 | ||
| EV/EBITDA | 13.25 |
4.3 Compensation for Growth
BIM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of BIM may justify a higher PE ratio.
A more expensive valuation may be justified as BIM's earnings are expected to grow with 13.42% in the coming years.
PEG (NY)1.7
PEG (5Y)2.56
EPS Next 2Y14.56%
EPS Next 3Y13.42%
5. Dividend
5.1 Amount
BIM has a yearly dividend return of 0.79%, which is pretty low.
BIM's Dividend Yield is comparable with the industry average which is at 1.13.
Compared to an average S&P500 Dividend Yield of 1.92, BIM's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.79% |
5.2 History
On average, the dividend of BIM grows each year by 19.40%, which is quite nice.
Dividend Growth(5Y)19.4%
Div Incr Years1
Div Non Decr Years7
5.3 Sustainability
28.07% of the earnings are spent on dividend by BIM. This is a low number and sustainable payout ratio.
BIM's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.07%
EPS Next 2Y14.56%
EPS Next 3Y13.42%
EPA:BIM (1/13/2026, 7:00:00 PM)
108
-1.4 (-1.28%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners21.47%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap12.78B
Revenue(TTM)4.12B
Net Income(TTM)378.00M
Analysts75.29
Price Target128.35 (18.84%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.79% |
Yearly Dividend0.85
Dividend Growth(5Y)19.4%
DP28.07%
Div Incr Years1
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.62%
PT rev (3m)0.23%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.1%
EPS NY rev (3m)-2.56%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)-0.83%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.98 | ||
| Fwd PE | 21.32 | ||
| P/S | 3.1 | ||
| P/FCF | 29.13 | ||
| P/OCF | 16.23 | ||
| P/B | 3.25 | ||
| P/tB | 4.57 | ||
| EV/EBITDA | 13.25 |
EPS(TTM)3.86
EY3.57%
EPS(NY)5.07
Fwd EY4.69%
FCF(TTM)3.71
FCFY3.43%
OCF(TTM)6.65
OCFY6.16%
SpS34.82
BVpS33.24
TBVpS23.61
PEG (NY)1.7
PEG (5Y)2.56
Graham Number53.73
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.04% | ||
| ROE | 9.61% | ||
| ROCE | 11.7% | ||
| ROIC | 8.56% | ||
| ROICexc | 9.38% | ||
| ROICexgc | 13.1% | ||
| OM | 12.38% | ||
| PM (TTM) | 9.17% | ||
| GM | 56.27% | ||
| FCFM | 10.65% |
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
ROICexc(3y)11.26%
ROICexc(5y)13.92%
ROICexgc(3y)17.24%
ROICexgc(5y)22.12%
ROCE(3y)13.71%
ROCE(5y)16.2%
ROICexgc growth 3Y-22.62%
ROICexgc growth 5Y-8.16%
ROICexc growth 3Y-19.11%
ROICexc growth 5Y-1.66%
OM growth 3Y-12.86%
OM growth 5Y2.09%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
F-Score8
Asset Turnover0.77
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 1.15 | ||
| Debt/EBITDA | 0.36 | ||
| Cap/Depr | 73.43% | ||
| Cap/Sales | 8.46% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 79.94% | ||
| Profit Quality | 116.09% | ||
| Current Ratio | 2.27 | ||
| Quick Ratio | 1.3 | ||
| Altman-Z | 6.82 |
F-Score8
WACC7.91%
ROIC/WACC1.08
Cap/Depr(3y)244.38%
Cap/Depr(5y)271.63%
Cap/Sales(3y)8.63%
Cap/Sales(5y)8.67%
Profit Quality(3y)48.66%
Profit Quality(5y)62.08%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.45%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%-25.82%
EPS Next Y16.45%
EPS Next 2Y14.56%
EPS Next 3Y13.42%
EPS Next 5Y11.79%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%7.46%
Revenue Next Year5.19%
Revenue Next 2Y5.72%
Revenue Next 3Y6.1%
Revenue Next 5Y5.72%
EBIT growth 1Y-1.73%
EBIT growth 3Y-7.95%
EBIT growth 5Y10.54%
EBIT Next Year64.69%
EBIT Next 3Y25.44%
EBIT Next 5Y17.89%
FCF growth 1Y133.53%
FCF growth 3Y-15.59%
FCF growth 5Y18.88%
OCF growth 1Y66.81%
OCF growth 3Y-6.82%
OCF growth 5Y10.35%
BIOMERIEUX / BIM.PA FAQ
What is the ChartMill fundamental rating of BIOMERIEUX (BIM.PA) stock?
ChartMill assigns a fundamental rating of 6 / 10 to BIM.PA.
What is the valuation status of BIOMERIEUX (BIM.PA) stock?
ChartMill assigns a valuation rating of 4 / 10 to BIOMERIEUX (BIM.PA). This can be considered as Fairly Valued.
What is the profitability of BIM stock?
BIOMERIEUX (BIM.PA) has a profitability rating of 6 / 10.
Can you provide the financial health for BIM stock?
The financial health rating of BIOMERIEUX (BIM.PA) is 8 / 10.
How sustainable is the dividend of BIOMERIEUX (BIM.PA) stock?
The dividend rating of BIOMERIEUX (BIM.PA) is 3 / 10 and the dividend payout ratio is 28.07%.